Interestingly, the authors noted that pCR appeared independent of baseline CD8+ T-cell presence or T-effector signatures, though absence of pre-surgical circulating tumor DNA in plasma was potentially predictive of PFS. The gene discussed is CD8A; the disease is neoplasm.